Challenge Dose Administration of Twinrix™ or Comparator 4 Years After Primary Vaccination.

Trial Profile

Challenge Dose Administration of Twinrix™ or Comparator 4 Years After Primary Vaccination.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Mar 2017

At a glance

  • Drugs Hepatitis A-hepatitis B vaccine (Primary) ; Hepatitis A vaccine inactivated; Hepatitis B vaccine recombinant
  • Indications Hepatitis A; Hepatitis B
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 10 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top